PE backed B2B/B2C healthcare technology company empowering customers with software solutions to optimize pharmacy administration and to maximize prescription drug savings. SingleCare, a division of RxSense, is the nation’s fastest growing direct-to-consumer prescription drug savings and digital patient services platform. Leading, developing and launching the value creation and end-to-end growth strategies for a brand-new business division focused on providing DTC digital patient acquisition and engagement solutions for pharmaceutical companies, their advertising agencies and healthcare industry affiliated organizations Responsible for leading all aspects of newly created Pharmaceutical Solutions business division currently in start-up phase; full P&L ownershipSuccessfully delivering on product, technology, resource, sales and marketing micro business plans in pursuit of aggressive new incremental revenue targets in 2023Driving success through building up of VP-level management team and collaboration with extended team of 100+ members focused on engineering, product development, ad operations, sales, marketing, account management and business/customer-level analytics. Force behind data-driven customer acquisition (SEO/SEM) strategies; ensuring deep-in-funnel patient targets and optimizing new patient starts for pharmaceutical clientsLeading pharmaceutical and biotech customer engagements for new offering; securing many early adopters of new service offering in first 3 months of launch and positioning the new division to exceed its year-one performance objectives

National independent specialty pharmacy organization with over 400 employees operating in 12 locations throughout the United States supporting patients, pharmaceutical/biotech companies, payers and physicians in the management and access to specialty pharmaceuticals and infused medications via traditional prescription dispensing and in-home clinical servicesAs CGO, I have overall responsibility and accountability for developing and implementing the value creation and growth strategies of the organization and maintain active engagement with our Board of Directors and Private Equity partners regarding same. I lead a cross-functional team of senior executive leaders responsible for national provider-facing sales, managed markets (payer) access, 340B, Pharma Relations, marketing and M&A targeting and diligence.

Top-tier national pharmaceutical consulting firm focused on end-to-end pharma/biotech commercialization design and issue resolutions•Assisted Pharmaceutical/Biotech, Specialty Pharmacy and Home Infusion companies to address pressing business challenges, emergent marketplace dynamics requiring refinements in strategies/tactics and full specialty drug launch planning and implementation; •Successfully supported end-to-end commercialization efforts in traditional Specialty, Orphan/Rare Diseases, Advanced Therapies, distribution, channel, REMS, 340B, adherence and patient access

Global Fortune 6 pharmaceutical and healthcare services organization with 80,000+ employees primarily providing comprehensive drug supply chain logistics to millions of healthcare entities. The Life Sciences division contains the direct patient-engagement functions of the corporation; focusing on assisting pharmaceutical/biotech companies with commercialization services for patients and physicians seeking access to/adherence support with specialty medicinesAssembled and led a cross-functional management team of 15 senior executives to oversee operations and organic/acquisitive growth strategies for complex healthcare services business portfolio consisting of four distinct businesses across the United States focused on delivering pharma-sponsored patient services (HUB), non-commercial pharmacy services, adherence and clinical support via high-tech digital engagement offerings and traditional contact center supported individualized case management services.

• Led end-to-end B2B strategy, sales, marketing, product development and customer engagement functions for the patient services/HUB life sciences business. • Direct management of nationally focused business development/sales team of 25 individuals. • Consistently exceeded revenue and EBIT targets; expanded customer base from 11 unique customers to 70+

•Active in the development of Specialty business strategy plan ultimately resulting in the acquisition of Oncology Therapeutics Network (OTN), Mosaic Consulting, National Oncology Alliance (NOA) GPO and US Oncology •Led all sales and marketing strategies for specialty distribution, pharmacy, patient services, and oncology GPO businesses that contributed to a 50% increase in sales in 18 months

Director, Managed Care MarketingDirector, Patient Access & Reimbursement ProgramsDirector, Pricing Strategy/Value of Pharmaceuticals & Policy Director, Economic Affairs